Fuentes, Jessa Lea .

HRN: 27-45-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 500MG (TAB)
08/22/2025
08/24/2025
ORAL
500 Mg
BID X 7days
Sp NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines